drugset / Trial / NCT03072719

The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity

NCT03072719 ↗

Phase 3 Completed 120 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomised, examiner blind, two treatment arm, stratified, parallel design, single-site study in subjects with at least two sensitive teeth to compare the efficacy of a test dentifrice against that of a control dentifrice in reducing dentinal hypersensitivity.

Timeline

Start
2012-03-01
Primary completion
2012-06-01
Completion
2012-06-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Experimental Dentifrice vs Reference Dentifrice; p = 0.1774; Least square (LS) mean difference -0.19 (95% CI -0.46 to 0.09); ANCOVA; NCT03072719 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown — Topical
Subject stannous fluoride Small molecule 0.454 % Topical

Indications